You have 9 free searches left this month | for more free features.

Omalizumab

Showing 1 - 25 of 256

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Spontaneous Urticaria, Chronic Urticaria, Idiopathic Trial in Copenhagen (omalizumab 300 mg every four weeks, omalizumab

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Chronic Urticaria, Idiopathic
  • omalizumab 300 mg every four weeks
  • omalizumab 300 mg every six weeks
  • Copenhagen, Copenhagen N, Denmark
    Department of Dermatology, Bispebjerg Hospital
Jun 21, 2023

Chronic Spontaneous Urticaria Trial (Remibrutinib, Placebo to remibrutinib, Placebo to omalizumab)

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • (no location specified)
Sep 20, 2023

Allergic Asthma Trial (omalizumab, )

Completed
  • Allergic Asthma
  • omalizumab
  • placebo
  • (no location specified)
Dec 9, 2022

Chronic Rhinosinusitis With Nasal Polyps, Nasal Polyps Trial in Baltimore (Omalizumab)

Recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • Nasal Polyps
  • Omalizumab
  • Baltimore, Maryland
  • +1 more
Jan 18, 2023

Asthma in Children, Atopy, Viral Upper Respiratory Infection Trial in Washington (Omalizumab, Placebo)

Recruiting
  • Asthma in Children
  • +2 more
  • Omalizumab
  • Placebo
  • Washington, District of Columbia
    Children's National Hospital
Aug 26, 2022

Covid19 Trial in Niagara, Toronto, Montreal (Omalizumab, Placebo)

Active, not recruiting
  • Covid19
  • Omalizumab
  • Placebo
  • Niagara, Ontario, Canada
  • +2 more
Nov 14, 2022

Food Allergy Trial in Odense C (Omalizumab, Placebo)

Recruiting
  • Food Allergy
  • Omalizumab
  • Placebo
  • Odense C, Funen, Denmark
    Odense Research Center for Anaphylaxis, Allergy Center, Odense U
Sep 20, 2022

Omalizumab in Children With Allergic Asthma.

Completed
  • Allergic Asthma
  • Omalizumab
  • East Hanover, New Jersey
    Novartis Investigative Site
Jun 29, 2022

Xolair (OMALIZUMAB) in Chronic Spontaneous Urticaria

Recruiting
  • Spontaneous Urticaria, Chronic
    • Lille, France
      Hop Claude Huriez Chu Lille
    Jan 25, 2023

    Nasal Polyps Trial in Shiraz (Omalizumab, SNOT22 score)

    Not yet recruiting
    • Nasal Polyps
    • Omalizumab
    • SNOT22 score
    • Shiraz, Fars, Iran, Islamic Republic of
      Imam Reza Allergy and Immunology clinic, Shiraz University of Me
    May 31, 2022

    Xolair® in Pediatric Chronic Spontaneous Urticaria in China

    Not yet recruiting
    • Chronic Spontaneous Urticaria
    • Xolair
    • (no location specified)
    Sep 19, 2023

    Allergic Asthma, Uncontrolled Moderate to Severe Trial in Iran, Islamic Republic of (Omalizumab (CinnaGen), Omalizumab

    Completed
    • Allergic Asthma
    • Uncontrolled Moderate to Severe
    • Omalizumab (CinnaGen)
    • Omalizumab (Genentech, Inc., USA and Novartis Pharmaceuticals Corp, Switzerland)
    • Ahvaz, Iran, Islamic Republic of
    • +21 more
    Apr 3, 2023

    Chronic Idiopathic Urticaria Trial (Omalizumab Injection, Xolair Prefilled Syringe)

    Not yet recruiting
    • Chronic Idiopathic Urticaria
    • Omalizumab Injection
    • Xolair Prefilled Syringe
    • (no location specified)
    Mar 7, 2023

    Asthma, Allergic Trial (omalizumab)

    Not yet recruiting
    • Asthma, Allergic
    • omalizumab
    • (no location specified)
    Aug 30, 2023

    XOLAIR Outcomes in Pediatric Allergic Asthma United States

    Completed
    • Asthma
    • Omalizumab
    • East Hanover, New Jersey
      Novartis Investigational Site
    Dec 15, 2021

    Food IgE-mediated Allergy, Immunotherapy, Omalizumab Trial in Toronto, Montréal, Sherbrooke (Omalizumab 16mg/kg, Omalizumab

    Recruiting
    • Food IgE-mediated Allergy
    • +3 more
    • Omalizumab 16mg/kg
    • +3 more
    • Toronto, Ontario, Canada
    • +2 more
    Jan 31, 2022

    Food Allergy Trial (Drug: Chinese Herbal Medication, Drug: Placebo, Drug: Omalizumab)

    Completed
    • Food Allergy
    • Drug: Chinese Herbal Medication
    • +2 more
    • (no location specified)
    Oct 24, 2023

    Healthy Volunteers Trial in Shanghai (CMAB007, Xolair)

    Completed
    • Healthy Volunteers
    • CMAB007
    • Xolair
    • Shanghai, China
      Shanghai Xuhui Central Hospital
    Jun 8, 2023

    Fluctuation Analyses of Asthma Patients With Biologics Use

    Not yet recruiting
    • Asthma
    • Biological Drug
    • (no location specified)
    Sep 7, 2023

    Asthma, Infertility, Female Trial in Copenhagen (Omalizumab Injection, NaCl)

    Recruiting
    • Asthma
    • Infertility, Female
    • Omalizumab Injection
    • NaCl
    • Copenhagen, Denmark
      Charlotte Suppli Ulrik
    Dec 16, 2021

    Omalizumab on Corticosteroid Use, Emergency Room Visits and

    Withdrawn
    • Asthma
      • (no location specified)
      Nov 23, 2021

      Asthma Trial in Paris (Attempt to withdrawal OMA treatment, Continuation of OMA treatment)

      Recruiting
      • Asthma
      • Attempt to withdrawal OMA treatment
      • Continuation of OMA treatment
      • Paris, Île De France, France
        Höpital Bichat-Claude Bernard
      Feb 9, 2022

      Asthma Trial in Shanghai (Omalizumab)

      Completed
      • Asthma
      • Omalizumab
      • Shanghai, Shanghai, China
        Shanghai Xuhui Central Hospital
      Oct 8, 2021

      Chronic Urticaria, Idiopathic Trial in Aurora (Omalizumab)

      Recruiting
      • Chronic Urticaria, Idiopathic
      • Omalizumab
      • Aurora, Colorado
        University of Colorado Anschutz
      Mar 23, 2022

      Chronic Rhinosinusitis With Nasal Polyps Trial in Ghent (Mepolizumab)

      Recruiting
      • Chronic Rhinosinusitis With Nasal Polyps
      • Mepolizumab
      • Ghent, Belgium
        Ghent University Hospital
      Jul 6, 2023